Educational guide
HA-DOTATATE Radioligand | JPT Peptide
HA-DOTATATE - Radioligand US$1,926.40 Excluding tax and shipping fees In stock Description About HA-DOTATATE - Radioligand HA-DOTATATE - Radioligand, precursor for radiolabeled HA-DOTATATE and ligand for somatostatin receptors. Can be bound to radionuclides fo
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
HA-DOTATATE - Radioligand
US$1,926.40
Excluding tax and shipping fees
In stock
Description
About HA-DOTATATE - Radioligand
HA-DOTATATE - Radioligand, precursor for radiolabeled HA-DOTATATE and ligand for somatostatin receptors. Can be bound to radionuclides for development of cancer treatment and diagnosis. For research use only!
HA-DOTATATE - Radioligand - Specifications
Peptide sequence: DOTA-DPhe-C-Tyr(3-I)-DTrp-KTCT-OH (Tyr(3-I) = 3-iodo-L-tyrosine)
Amount: 1 mg (10 x100µg)
Purity: >95% (HPLC-MS)
Delivery Format: Freeze-dried in plastic vial
Application(s): Nuclear medicine
Condition(s)/Topic(s): Cancer
Standard Delivery Time: approx. 3 weeks
We provide the peptide in a range of aliquot sizes, ensuring flexibility for diverse research applications. For any special requirements, please contact our customer support: [email protected]
JPT’s Oncology Peptides
One focus of JPT’s product development is oncology. Therefore, we offer a huge variety of TAA peptide, peptide pools and microarrays, as well as DOTA peptides and radio sensitizers. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides in all formats, scales and modifications to the global scientific community. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.Have a look at our Peptide Tools to Study Cancer.
Benefits of JPT's Single Catalogue Peptides - Synthesis protocols designed to avoid toxic contaminants and side products - Provision of freeze dried aliquots for enhanced stability - Proven track record for applications in clinical studies
References
References for HA-DOTATATE - Radioligand
References:Read References with Specialty Peptides
Documentation
Documentation for HA-DOTATATE - Radioligand
HA-DOTATATE-Radioligand-1.pdf
Properties
Properties of HA-DOTATATE - Radioligand
Nuclear medicine
Chelate Peptides (DOTA)
Cancer
Freeze-dried in plastic vial
Artificial
Other
>95% (HPLC-MS)
No
Further Information to HA-DOTATATE - Radioligand
Values
DOTA-DPhe-C-Tyr(3-I)-DTrp-KTCT-OH (Tyr(3-I) = 3-iodo-L-tyrosine)
Related Products
Related Products
Vipivotide tetraxetan (PSMA-617) - CAS 1702967-37-0
US$2,568.60
NOTA-AMBA - Radioligand
US$1,926.45
PSMA-11 - Radioligand
US$1,996.45